US Patent Issued to SHENZHEN CELL INSPIRE PHARMACEUTICAL DEVELOPMENT on Nov. 25 for "Hydrazone amide derivative and application thereof in preparation of medicaments for preventing and treating alopecia" (Chinese Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,479,809, issued on Nov. 25, was assigned to SHENZHEN CELL INSPIRE PHARMACEUTICAL DEVELOPMENT Co. LTD. (Guangdong, China).

"Hydrazone amide derivative and application thereof in preparation of medicaments for preventing and treating alopecia" was invented by Dane Huang (Guangdong, China), Chao Zhao (Guangdong, China), Qiong Gu (Guangdong, China) and Jun Xu (Guangdong, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides a brand-new hydrazone amide derivative and an application thereof in preparation of medicaments for preventing and treating alopecia. The structural formula of the hydrazone amide derivative is shown in for...